Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding?

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1689-1692

  Acmaz, Gokhan ^a   Aksoy, Huseyin ^a   Unal, Dilek ^b   Ozyurt, Sezin ^a   Cingillioglu, Basak ^a   Aksoy, Ulku ^a   Muderris, Ipek ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b Kayseri Education and Research Hospital ^*  (Turkey)

Author keywords

Endometrial cancer; Endometrial hyperplasia; Neutrophil to lymphocyte ratio; Platelet to lymphocyte ratio

Indexed keywords

ADULT; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; CYTOLOGY; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYPERPLASIA; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PRECANCER; RETROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE COUNT; UTERUS BLEEDING;

ADULT; BLOOD PLATELETS; CROSS-SECTIONAL STUDIES; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYPERPLASIA; LYMPHOCYTE COUNT; LYMPHOCYTES; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; UTERINE HEMORRHAGE;

EID: 84896966629     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1689     Document Type: Article

References (24)

1. Alexandrakis MG, Passam FH, Moschandrea IA, et al (2003). Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol, 26, 135-40.
2. Babu SN, Chetal G, Kumar S (2012). Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy. Asian Pac J Cancer Prev, 13, 1737-44.
3. Choi CH, Kang H, Kim WY, et al (2008). Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation. Int J Radiat Oncol Biol Phys, 71, 199-204.
4. Choi CH, Kim TJ, Lee JW, et al (2006). Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma. Gynecol Oncol, 104, 64-9.
5. Fridlender ZG, Sun J, Kim S, et al (2009). Polarization of tumor-associated neutrophil phenotype by TGFβ: "N1" versus "N2" TAN. Cancer Cell, 16, 183-94.
6. Fukunaga A, Miyamoto M, Cho Y, et al (2004). CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas, 28, 26-31.
7. Guo YZ, Lei Pan, Du CJ, Re DQ, Xie XM (2013). Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pacific J Cancer Prev, 14, 243-8.
8. Heller DS, Mosquera C, Goldsmith LT, Cracchiolo B (2011). Body mass index of patients with endometrial hyperplasia: comparison to patients with proliferative endometrium and abnormal bleeding. J Reprod Med, 56, 110-2.
9. Kao SC, Pavlakis N, Harvie R, et al (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res, 16, 5805-13.
10. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN (2009). Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol, 16, 614-22.
11. Kleebkaow P, Maneetab S, Somboonporn W, et al (2008). Preoperative and postoperative agreement of histopathological findings in cases of endometrial hyperplasia. Asian Pac J Cancer Prev, 9, 89-91.
12. Klinger MH, Jelkmann W (2002). Role of blood platelets in infection and inflammation. J Interferon Cytokine Res, 22, 913-22.
13. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH (2003). Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis, 6, 283-7.
14. Kwon HC, Kim SH, Oh SY, et al (2012). Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers, 17, 216-22.
15. Négrier S, Escudier B, Gomez F, et al (2002). Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d' Immunotherapie. Ann Oncol, 13, 1460-8.
16. Saito K, Tatokoro M, Fujii Y, et al (2009). Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. Eur Urol, 55, 1145-53.
17. Sharaiha RZ, Halazun KJ, Mirza F, et al (2011). Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol, 18, 3362-9.
18. Smith RA, Bosonnet L, Ghaneh P, et al (2008). The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery, 143, 658-66.
19. Tavares-Murta BM, Mendonca MA, Duarte NL, et al (2010). Systemic leukocyte alterations are associated with invasive uterine cervical cancer. Int J Gynecol Cancer, 20, 1154-9.
20. Teramukai S, Kitano T, Kishida Y, et al (2009). Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer, 45, 1950-8.
21. Toriola AT, Grankvist K, Agborsangaya CB, et al (2011). Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudal study. Ann Oncol, 22, 1916-21.
22. Turan T, Karadag B, Karabuk E, et al (2012). Accuracy of frozen sections for intraoperative diagnosis of complex atypical endometrial hyperplasia. Asian Pac J Cancer Prev, 13, 1953-6.
23. Unal D, Eroglu C, Kurtul N, Oguz A, Tasdemir A (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42.
24. Wang GY, Yang Y, Li H, et al (2011). A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of hbv-associated hepatocellular carcinoma after liver transplantation. PLoS One, 6, 25295.